Form 8-K - Current report:
SEC Accession No. 0001654954-25-008033
Filing Date
2025-07-14
Accepted
2025-07-14 16:25:11
Documents
19
Period of Report
2025-07-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K cvm_8k.htm   iXBRL 8-K 31654
2 PLACEMENT AGENCY AGREEMENT cvm_ex11.htm EX-1.1 273327
3 OPINION cvm_ex51.htm EX-5.1 7041
4 PRESS RELEASE cvm_ex991.htm EX-99.1 10403
5 PRESS RELEASE cvm_ex992.htm EX-99.2 10302
11 cvm_ex991img1.jpg GRAPHIC 4832
  Complete submission text file 0001654954-25-008033.txt   533532

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA cvm-20250711.xsd EX-101.SCH 5866
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE cvm-20250711_lab.xml EX-101.LAB 14667
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cvm-20250711_cal.xml EX-101.CAL 895
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cvm-20250711_pre.xml EX-101.PRE 9272
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cvm-20250711_def.xml EX-101.DEF 2096
21 EXTRACTED XBRL INSTANCE DOCUMENT cvm_8k_htm.xml XML 3883
Mailing Address 8229 BOONE BLVD. SUITE 802 VIENNA VA 22182
Business Address 8229 BOONE BLVD . SUITE 802 VIENNA VA 22182 7035069460
CEL SCI CORP (Filer) CIK: 0000725363 (see all company filings)

EIN.: 840916344 | State of Incorp.: CO | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-11889 | Film No.: 251121971
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)